Table 2.
Overall effect of inflammation-related markers.
| Period of Probiotic Intervention | Timing of Postassessment Blood Sampling | ||||
|---|---|---|---|---|---|
| Inflammation-Related Marker | Overall Effect | Shorter Period | Longer Period | Delayed to at Least the Next Day of Exercise | Immediate Assessment after Exercise |
| TNF-α | −0.29 | −0.59 | −0.15 | −0.26 | −0.57 |
| (−0.42, −0.16) | (−0.81, −0.37) | (−0.30, 0.01) | (−0.40, −0.13) | (−0.99, −0.16) | |
| IL-6 | 0.19 | −0.11 | 0.20 | −0.77 | 0.36 |
| (−0.25, 0.63) | (−4.56, 4.34) | (−0.25, 0.64) | (−1.91, 0.37) | (−0.11, 0.84) | |
| IL-8 | −0.57 | −1.23 | −0.20 | −0.17 | −1.31 |
| (−1.33, 0.19) | (−2.48, 0.03) | (−1.15, 0.75) | (−1.11, 0.77) | (−2.59, −0.04) | |
| IL-10 | −0.1 | −0.13 | −0.33 | −0.12 | −0.52 |
| (−0.19, −0.06) | (−0.19, −0.06) | (−1.01, 0.35) | (−0.19, −0.05) | (−0.98, −0.07) | |
| IFN-γ | 14.33 | ||||
| (13.76, 14.89) | |||||
| IgA | 3.57 | ||||
| (0.66, 6.48) | |||||
| IL-β | −0.03 | ||||
| (−0.14, 0.08) | |||||
| IL-2 | −0.04 | ||||
| (−0.38, 0.31) | |||||
| IL-4 | −0.14 | ||||
| (−1.05, 0.77) | |||||
| CRP | −0.69 | ||||
| (−2.51, 1.13) | |||||